Dermagnostix - Molecular diagnostics

Dermagnostix closes the gap in dermatology that has arisen between highly efficient therapeutics on the one hand and inadequate, antiquated diagnostic procedures on the other. This is achieved by molecular diagnostics on the basis of own protected IP. The company uses the LabDisk technology from Hahn-Schickard, a fully automated, microfluidic analysis system for point-of-care diagnostics. With PsorEx-LabDisk, the world's first molecular test to differentiate between psoriasis and eczema - diseases that affect almost 10% of the world population - will be launched.

More information: Website of Dermagnostix

Institute of Microanalysis Systems

Location Freiburg

Prof. Dr.-Ing. Roland Zengerle
Georges-Köhler-Allee 103
79110 Freiburg
Phone: +49 761 203-73275


Location Ulm
Sedanstraße 14
89077 Ulm

Go back